✦ LIBER ✦

LETTER TO THE EDITOR. DE NOVO INTERSTITIAL PROXIMAL DELETION OF 14q AND PRENATAL DIAGNOSIS OF HOLOPROSENCEPHALY

✍ Scribed by H. BRUYERE; B. FAVRE; S. DOUVIER; A. NIVELON-CHEVALIER; F. MUGNERET

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 372 KB
Volume: 16
Category: Article
ISSN: 0197-3851
DOI: 10.1002/(sici)1097-0223(199611)16:11<1059::aid-pd993>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prenatal diagnosis of de novo interstiti

Prenatal diagnosis of de novo interstitial deletion of proximal 4q by maternal serum screening for Down syndrome

✍ Te-Yao Hsu; Fu-Tsai Kung; Chia-Yu Ou; Pi-Yu Hsiao; Fu-Jen Huang; Chan-Chao Chang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 1 views

Deletion of the proximal portion of chromosome 4q is apparently rare. To our knowledge, prenatal diagnosis of the interstitial deletion of 4q12-21.1 has never been reported. We present a prenatal case of 4q deletion in association with a positive Down syndrome screening test of an elevated maternal

Prenatal diagnosis of de novo interstiti

Prenatal diagnosis of de novo interstitial 16q deletion in a fetus associated with sonographic findings of prominent coronal sutures, a prominent frontal bone, and shortening of the long bones

✍ Chih-Ping Chen; Schu-Rern Chern; Chen-Chi Lee; Li-Feng Chen; Chun-Yu Chuang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

De novo interstitial 16q deletion diagnosed in utero has not previously been reported. We present a case of fetal de novo interstitial 16q deletion associated with the sonographic findings of prominent coronal sutures, a prominent frontal bone, and shortening of the long bones. Genetic amniocentesis

Letter to the editor: Lack of protection

Letter to the editor: Lack of protection of proximal tubular cells by amifostine (ethyol) in ifosfamide-containing regimens

✍ de Kraker, J.; Bierings, M.B.; Offringa, M. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 1 views

## Lack of Protection of Proximal Tubular Cells by Amifostine (Ethyol) in Ifosfamide-containing Regimens To the Editor: Ifosfamide (IF) is an effective drug in paediatric oncology [1]. However, there is great need for agents that can deal with the dose-limiting tubular toxicity of IF. Amifostine (